Out-of-Hospital Cardiac Arrest: Amiodarone and Lidocaine May Improve Survival Outcomes
There were no significant differences in survival to hospital discharge among the amiodarone, lidocaine, and placebo groups.
The reversal agent, andexanet alfa, effectively reduces life-threatening bleeding in patients treated with factor Xa inhibitors.
High levels of physical activity correlate with prevalent coronary artery calcification (CAC) but are not linked to increased mortality.
Metabolically healthy and unhealthy obesity increase atrial fibrillation risk at a similar rate.